How to Read Your Promethease Report Without Getting Overwhelmed

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Genetic variants discussed here are examples used to illustrate how to interpret Promethease reports. Always consult a qualified healthcare provider before making any health decisions based on genetic information. Genetic data should be interpreted in the context of your full medical history, lifestyle, and clinical assessment.

---

What Is a Promethease Report and Why Is It Hard to Read

Promethease is a literature-mining tool that cross-references your raw DNA data against SNPedia, a community-curated database of published genetic research. When you upload your 23andMe, AncestryDNA, or other raw data file, Promethease generates a report listing every SNP (single nucleotide polymorphism) in your file that has an entry in SNPedia — along with the associated research findings, magnitude scores, and reputed effects.

The result is a dense, unfiltered document. A typical Promethease report contains thousands of SNP entries, ranging from well-established variants with strong clinical evidence to obscure associations from single small studies. Without context, the report looks like an overwhelming wall of text full of medical jargon, rs-numbers, and probability estimates.

Many people open their Promethease report for the first time and feel immediate anxiety. They see phrases like "2.35x increased risk" or "associated with Alzheimer's disease" and don't know what to make of them. Others feel reassured by "good" variants without understanding that one SNP rarely tells the whole story.

This guide walks you through the entire process of reading a Promethease report with accuracy and calm. You'll learn how the scoring system works, how to filter out noise, which variants are worth attention, and how to think critically about what the results actually mean for your health. We'll also cover what Promethease cannot tell you — and where tools like Ask My DNA can help you ask specific follow-up questions about your own genetic data.

If you haven't yet obtained your raw DNA file, start with our guide on what to do with your 23andMe raw data after the bankruptcy situation, or explore the best DNA upload sites in 2026 for options beyond Promethease.

---

How Promethease Scores Variants: Magnitude, Frequency, and Repute

Before reading a single line of your report, you need to understand the three core metrics Promethease uses to describe each variant.

Magnitude

Magnitude is a numeric score assigned by SNPedia editors to indicate how significant a variant is considered to be. The scale runs roughly from 0 to 10, though scores above 4-5 are rare.

A magnitude score of 2.1 for rs4988235 (lactase persistence / lactose tolerance) is unremarkable. A magnitude of 4.0 for rs1799853 (CYP2C9*2, affecting warfarin metabolism) warrants discussion with your doctor if you ever need anticoagulant therapy.

Critical nuance: Magnitude reflects the editor's assessment of research significance, not the probability you will develop a condition. High-magnitude variants can be common in the population and carry modest actual risk.

Frequency

Frequency tells you how common your specific genotype is in the population Promethease uses as reference (typically 1000 Genomes or gnomAD data). This matters because:

• A "bad" variant present in 30% of the population has very different implications than one present in 0.1%
• Common variants usually have smaller effect sizes
• Rare variants with high magnitude deserve more careful attention

Repute

Repute is the simplest metric: good, bad, or not set. This is a rough categorization based on SNPedia entries. "Bad" does not mean you will get a disease — it means the variant has been associated with a less favorable outcome in some studies. "Good" means associated with a beneficial effect.

Do not make health decisions based on repute alone. A variant labeled "bad" for one condition (e.g., rs1801282 in PPARG associated with slightly higher type 2 diabetes risk) may have no practical impact on a person with a healthy lifestyle.

---

Navigating the Promethease Interface: Filters That Actually Matter

The Promethease web interface offers several filtering options. Using them strategically is the difference between a useful analysis session and an anxiety spiral.

The Magnitude Filter

Start by setting the magnitude filter to 3.0 or higher. This immediately reduces thousands of entries to a manageable subset of variants with meaningful research backing. Most people have fewer than 100 variants at magnitude 3+.

Once you've reviewed those, you can lower the threshold to 2.5 to catch moderately interesting findings, but don't start there.

The Frequency Filter

Filter by frequency to focus on variants that are either:

• Rare (frequency < 5%) with high magnitude — these are the variants most worth discussing with a clinician
• Common (frequency > 30%) — useful context, but usually lower individual impact

Avoid spending time on medium-frequency, low-magnitude entries during your first pass.

Searching by Gene Name

Use the search function to look up specific genes you're interested in. For example:

• Type MTHFR to find all MTHFR-related variants in your report
• Type APOE to go directly to Alzheimer's and cardiovascular risk variants
• Type CYP2D6 for drug metabolism findings

This topic-based approach is more actionable than scrolling through a ranked list.

Sorting by Magnitude (Descending)

Always start your session sorted by magnitude, highest first. This puts the most clinically significant findings at the top. The default sort in Promethease is by magnitude, but confirm this before you begin reading.

The "Bad" Repute Filter

You can filter to show only "bad" repute variants. This is useful, but use it as a second pass — not your primary view. Starting with only "bad" variants creates psychological bias and causes you to miss protective "good" variants that provide important context.

---

High-Priority SNPs: What to Actually Pay Attention To

With your filters set to magnitude 3+, you'll see a specific subset of variants. Here's how to interpret the most commonly appearing high-magnitude SNPs across major health categories.

Cardiovascular Risk

rs429358 and rs7412 (APOE gene)

These two SNPs together determine your APOE haplotype. The combinations give you e2, e3, or e4 variants:

APOE e4 carriers have 3-4x increased Alzheimer's risk compared to the common e3/e3 genotype. Two copies (e4/e4) carry approximately 8-12x increased lifetime risk. However, carrying APOE e4 does not guarantee Alzheimer's disease — many e4 carriers never develop it.

rs1801133 (MTHFR C677T)

This is one of the most commonly discussed variants in consumer genetics. The T allele is associated with reduced MTHFR enzyme activity, which affects folate metabolism and homocysteine levels. For a deeper dive, see our guide on how to check MTHFR in your raw data.

• CC genotype: normal enzyme activity
• CT genotype: ~35% reduced activity
• TT genotype: ~70% reduced activity, associated with elevated homocysteine

rs1799853 (CYP2C92) and rs1057910 (CYP2C93)

These variants affect metabolism of warfarin, NSAIDs, and other drugs processed by the CYP2C9 enzyme. High magnitude in Promethease because dosing errors with anticoagulants can be dangerous.

Cancer Risk Markers

rs80357914 and rs80357906 (BRCA1) / rs80358520 (BRCA2)

Promethease will flag known pathogenic BRCA variants if they appear in your SNP array data. However, consumer DNA tests like 23andMe only genotype a small fraction of BRCA variants — they test for the most common ones but miss most rare pathogenic mutations. A negative Promethease report for BRCA does not mean you have no BRCA mutations.

rs2981582 (FGFR2)

Associated with modest increase in breast cancer risk (approximately 1.2-1.3x per risk allele). Common in the population; seen in many Promethease reports. Magnitude is typically around 2.5-3.0.

Metabolism and Nutrition

rs762551 (CYP1A2)

Determines caffeine metabolism speed. The A allele is associated with fast caffeine metabolism; CC genotype with slow metabolism and higher cardiovascular risk from heavy coffee consumption. A fun and accessible example for understanding how Promethease works.

rs4988235 (LCT / MCM6)

Lactase persistence — whether you can digest lactose as an adult. T allele = persistent lactase activity (can digest dairy). CC = likely lactose intolerant. Magnitude around 2.1. Good introductory example of a well-replicated, high-frequency, low-stakes variant.

rs9939609 (FTO)

One of the most studied obesity-associated variants. A allele associated with approximately 1.3x increased obesity risk per copy. Present in roughly 45% of Europeans. Important to understand this as a modest probabilistic association, not a deterministic outcome.

Drug Response

rs3745274 (CYP2B6)

Affects metabolism of several psychiatric medications, antivirals (efavirenz), and smoking cessation drugs (bupropion). High magnitude when present because dosing implications are clinically actionable.

rs4244285 (CYP2C19*2)

Loss-of-function variant affecting metabolism of clopidogrel (Plavix), PPIs, and several antidepressants. Poor metabolizers may have reduced antiplatelet effect from clopidogrel — significant for cardiovascular patients.

---

Common Mistakes When Interpreting Promethease Results

Even careful readers make predictable errors when first working through a Promethease report. Understanding these mistakes in advance significantly improves the quality of your interpretation.

Mistake 1: Treating Association as Causation

A SNP "associated with" a disease does not cause the disease. The association may reflect a statistical correlation in a population study. Your individual risk depends on thousands of genetic variants acting together, plus environmental and lifestyle factors. A single rs-number rarely determines health outcomes.

Mistake 2: Ignoring Effect Size

Promethease shows relative risk, not absolute risk. A "2x increased risk" for a condition with 0.1% baseline prevalence means your risk is 0.2% — still very low. Always try to find the baseline population risk before interpreting relative risk multipliers.

Mistake 3: Fixating on "Bad" Variants While Ignoring "Good" Ones

Most people have hundreds of both "good" and "bad" variant calls. The balance matters. Someone anxious about a rs429358 APOE e4 variant should also note if they carry protective variants in TOMM40, CLU, or CR1 that modulate Alzheimer's risk.

Mistake 4: Accepting Outdated Citations

SNPedia entries are community-maintained and sometimes reference older studies that have been contradicted by larger meta-analyses. Always check the publication date of cited studies. Research published before 2015 on complex disease genetics should be treated with extra skepticism.

Mistake 5: Treating Consumer Array Data as Clinical-Grade

Consumer DNA tests genotype approximately 600,000–900,000 SNPs out of ~3 billion base pairs. Most of your genome is not tested. For clinical decisions, whole exome or whole genome sequencing from a clinical laboratory is required. Promethease is an educational tool, not a diagnostic device.

Mistake 6: Panic Over High-Magnitude Rare Variants

Promethease sometimes flags variants based on a single case report or small study. A magnitude of 4 based on one study of 50 people is very different from a magnitude of 4 based on 50,000-person GWAS meta-analysis. Check how many studies and participants back each claim.

---

How to Cross-Reference Promethease Findings With ClinVar and PubMed

Promethease links each SNP entry to SNPedia, which in turn links to PubMed studies and sometimes ClinVar entries. Using these primary sources improves your interpretation accuracy.

Using ClinVar

ClinVar is the NIH database of clinically reviewed variant interpretations. When Promethease flags a variant, search for its rs-number in ClinVar to see:

• Clinical significance: pathogenic, likely pathogenic, uncertain significance (VUS), likely benign, benign
• Review status: number of stars indicates evidence quality (1-4 stars)
• Condition: specific disease the classification applies to
• Submitters: which clinical labs have reported this variant

A variant with "pathogenic" classification from multiple 4-star ClinVar submissions is very different from one with a single "uncertain significance" entry.

Using PubMed

For each Promethease entry, check the linked PubMed studies:

1. Look at the study size (n=). Larger studies are more reliable for common variant associations.
2. Check the study design. GWAS (genome-wide association studies) and meta-analyses are more robust than candidate gene studies.
3. Note the population studied. A variant significant in European populations may have different effect sizes in other ancestries.
4. Look at replication. Has the finding been replicated in independent cohorts?

PubMed allows free access to abstracts and many full texts.

Cross-Referencing With dbSNP

dbSNP provides technical data about each variant: genomic location, allele frequencies by population, functional annotations, and links to related databases. Use dbSNP when you want to verify that Promethease is interpreting your genotype correctly, especially for strand orientation issues.

---

Organizing Your Findings: Building a Personal Genetic Summary

After your first pass through Promethease at magnitude 3+, build a simple personal summary document. This serves two purposes: it organizes your thinking, and it gives you something concrete to share with a healthcare provider.

Suggested Summary Structure

Tier 1 — High Priority (Magnitude 4+, clinical relevance)

• APOE genotype and Alzheimer's/cardiovascular implications
• Any BRCA or Lynch syndrome variants flagged
• High-impact pharmacogenomics variants (CYP2C9, CYP2C19, DPYD, TPMT)

Tier 2 — Medium Priority (Magnitude 3–4, discuss with doctor)

• MTHFR status and folate metabolism
• Key cardiovascular risk variants (F5 rs6025 for Factor V Leiden, F2 rs1799963 for prothrombin mutation)
• Thyroid-related variants if symptomatic

Tier 3 — Lifestyle Interest (Magnitude 2–3, self-management)

• Caffeine metabolism (CYP1A2 rs762551)
• Lactose tolerance (LCT rs4988235)
• Vitamin D metabolism (VDR rs2228570, CYP2R1 rs10741657)
• Omega-3 response (FADS1 rs174537)

Tier 4 — Curiosity Only (Magnitude < 2)

• Earwax type (ABCC11 rs17822931)
• Bitter taste perception (TAS2R38 rs713598)
• Asparagus anosmia (rs4481887)

This tiered approach prevents tier 4 curiosity findings from generating the same concern as tier 1 clinical variants.

What to Bring to Your Doctor

Bring your tier 1 and tier 2 summary, not the full Promethease report. Most clinicians do not have time to interpret a 500-page raw report. A focused one-page summary of your highest-magnitude findings, with the rs-numbers and associated conditions, allows for a productive clinical conversation.

If you are unsure which findings from your Promethease report are worth discussing, tools like Ask My DNA let you upload your raw genetic data and ask natural-language questions about specific variants — including "which of my variants are most worth discussing with my cardiologist?" Try it free with 3 questions, no credit card required.

---

Promethease vs. Other DNA Interpretation Tools

Promethease is one of several tools available for interpreting raw DNA data. Understanding how it compares helps you choose the right tool for specific questions.

For a detailed comparison, see our guide on SelfDecode vs Promethease vs Genetic Genie.

Promethease excels at breadth — it will show you everything SNPedia knows about your variants. But its strength is also its weakness: the unfiltered output requires significant genetic literacy to interpret. Tools with more curated outputs sacrifice breadth for accessibility.

If Promethease feels overwhelming, Promethease alternatives in 2026 covers other tools that provide guided interpretation with less manual filtering required.

---

Understanding Polygenic Risk Scores in the Context of Promethease

Promethease displays individual SNP associations, but most common diseases are polygenic — influenced by hundreds or thousands of variants simultaneously. This creates an important interpretive gap.

What Polygenic Risk Scores Are

A polygenic risk score (PRS) aggregates the effects of many variants to estimate overall genetic risk for a condition. A person in the top 10% of PRS for coronary artery disease has roughly 3x higher risk than average — a more accurate risk estimate than any single SNP provides.

Promethease does not calculate PRS. It shows you individual pieces of the puzzle, not the assembled picture. This means:

• You might have a "bad" APOE variant but a low overall polygenic risk for Alzheimer's due to protective variants elsewhere
• You might have no individual high-magnitude variants but still have elevated polygenic risk for a condition
• Single-SNP interpretation systematically overestimates some risks and underestimates others

Practical Implication

When Promethease shows you a risk variant, ask: "How does this fit with my overall genetic profile?" Some newer tools incorporate PRS calculations. For conditions like type 2 diabetes, coronary artery disease, and breast cancer, PRS-based risk tools are becoming clinically available and are significantly more accurate than single-variant approaches.

---

Frequently Asked Questions

Is a Promethease report the same as clinical genetic testing?

No. Promethease interprets raw data from consumer DNA arrays, which genotype approximately 600,000–900,000 pre-selected positions in your genome. Clinical genetic testing (such as BRCA testing ordered by an oncologist) uses different methods — targeted sequencing, whole exome sequencing, or whole genome sequencing — and provides clinical-grade accuracy with interpretation by certified genetic counselors. Consumer array data can miss pathogenic variants not included in the array design. Never use Promethease as a substitute for clinically ordered genetic testing when a specific diagnosis or treatment decision is involved.

My Promethease report shows a "bad" APOE e4 variant. Should I be worried?

Carrying one copy of APOE e4 increases lifetime Alzheimer's risk approximately 3-4x compared to the common e3/e3 genotype, but the majority of e4 carriers do not develop Alzheimer's. Two copies (e4/e4) carry higher risk but still not certainty. Lifestyle factors — cardiovascular health, exercise, sleep, cognitive engagement — significantly modify risk. If you carry APOE e4 and are concerned, discuss it with a physician or genetic counselor who can put the risk in the context of your full medical history and help with evidence-based prevention strategies.

How do I know which Promethease findings are based on strong evidence vs. weak studies?

Check three things: (1) the number of studies cited in the SNPedia entry, (2) the sample sizes of those studies — genome-wide association studies with 10,000+ participants are much more reliable than small candidate gene studies, and (3) whether the finding has been replicated in independent cohorts. ClinVar's star rating system (1-4 stars) provides a useful quality indicator for clinically classified variants. For research associations rather than clinical classifications, PubMed meta-analyses and systematic reviews provide the strongest evidence.

Can I use Promethease to find out if I carry disease genes I should tell my family about?

Promethease can flag well-known pathogenic variants in genes like BRCA1, BRCA2, MLH1, MSH2 (Lynch syndrome), and others if those variants happen to be included in your consumer DNA array. However, consumer arrays cover only a fraction of known pathogenic variants. A negative Promethease result for BRCA, for example, cannot rule out BRCA mutations. If you have a family history suggesting hereditary cancer syndrome or other serious hereditary conditions, pursue clinical genetic testing and counseling rather than relying on consumer array data and Promethease. For family communication about genetic findings, work with a certified genetic counselor.

Is my Promethease data private?

Promethease processes your raw DNA file and generates a report. Review their current privacy policy before uploading, as policies change. Your raw DNA file contains your entire genotyped sequence — it is among the most sensitive data you can share. Use a trusted email address, understand the data retention policy, and consider whether you're comfortable with the terms before uploading. For general guidance on managing your raw DNA data, see our article on free DNA health analysis and what you might be missing.

---

Conclusion

A Promethease report is a powerful educational resource, but it requires the right framework to be useful rather than overwhelming. Start with high-magnitude variants (3.0+), understand the difference between association and causation, cross-reference important findings with ClinVar and PubMed, and build a tiered personal summary that separates clinical priorities from lifestyle curiosity.

The most important insight is this: no single SNP determines your health destiny. Genetic risk is probabilistic, polygenic, and profoundly modifiable by environment and behavior. A Promethease report gives you data points — transforming those data points into actionable health decisions requires context, clinical judgment, and often a conversation with a healthcare provider or genetic counselor.

If you want to explore specific variants from your Promethease report in plain English, Ask My DNA lets you upload your raw DNA file and ask natural-language questions about your results. Start with 3 free questions — no credit card needed — and see which of your variants are worth a closer look.

---